Rubric Capital Management (New York)’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-310,959	Closed	-$687K	–	74
2024 Q1	$687K	Buy	+310,959	New	+$687K	0.02%	67
2023 Q2	–	Sell	-426,267	Closed	-$695K	–	74
2023 Q1	$695K	Buy	+426,267	New	+$695K	0.02%	69